99 related articles for article (PubMed ID: 1810221)
1. Lymphotoxin production in multiple sclerosis patients.
Głabiński A; Pokoca L; Tchórzewski H; Selmaj K
Arch Immunol Ther Exp (Warsz); 1991; 39(3):285-90. PubMed ID: 1810221
[TBL] [Abstract][Full Text] [Related]
2. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
[TBL] [Abstract][Full Text] [Related]
3. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
Mokhtarian F; Shi Y; Shirazian D; Morgante L; Miller A; Grob D
J Immunol; 1994 Jun; 152(12):6003-10. PubMed ID: 8207225
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic activity of lymphocytes. VII. cellular origin of alpha-lymphotoxin.
Yano K; Lucas ZJ
J Immunol; 1978 Feb; 120(2):385-94. PubMed ID: 146053
[TBL] [Abstract][Full Text] [Related]
5. Lymphotoxin and chemotactic factor produced in vitro by human lymphocytes during their proliferative response in the presence of phytohaemagglutinin and Nocardia water-soluble mitogen.
Prieur AM; Pham Huu T
Ann Immunol (Paris); 1980; 131D(2):223-32. PubMed ID: 6970542
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-induced plasma cell differentiation in patients with multiple sclerosis.
Levitt D; Griffin NB; Egan ML
J Immunol; 1980 May; 124(5):2117-21. PubMed ID: 6965966
[TBL] [Abstract][Full Text] [Related]
7. Abnormal regulation of in vitro IgG production in multiple sclerosis.
Kelly RE; Ellison GW; Myers LW; Goymerac V; Larrick SB; Kelley CC
Ann Neurol; 1981 Mar; 9(3):267-72. PubMed ID: 6452852
[TBL] [Abstract][Full Text] [Related]
8. [Interferon-producing and cytotoxic activity of natural killer cells in multiple sclerosis patients].
Sorokin AM; Koval'chuk LV; Tunkel' OI; Cheknev SB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(2):211-5. PubMed ID: 2437743
[TBL] [Abstract][Full Text] [Related]
9. In vitro T-cell dependent B-cell activity in myasthenia gravis.
Limburg PC; Hummel-Tappel E; Oosterhuis HJ; The TH
Clin Exp Immunol; 1985 Jul; 61(1):31-8. PubMed ID: 3876181
[TBL] [Abstract][Full Text] [Related]
10. T and B lymphocytes in multiple sclerosis.
Lisak RP; Levinson AI; Zweiman B; Abdou NI
Clin Exp Immunol; 1975 Oct; 22(1):30-4. PubMed ID: 1082395
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 2, interferon, and lymphotoxin in renal transplant recipients.
McKenna RM; Rush DN; Bakkestad-Legare P; Jeffery JR
Transplantation; 1988 Jan; 45(1):76-81. PubMed ID: 3122387
[TBL] [Abstract][Full Text] [Related]
12. PPD-, PWM-, and PHA-induced interferon in stable multiple sclerosis: association with HLA-Dw2 antigen and clinical variables.
Salonen R; Ilonen J; Reunanen M; Nikoskelainen J; Salmi A
Ann Neurol; 1982 Mar; 11(3):279-84. PubMed ID: 6178361
[TBL] [Abstract][Full Text] [Related]
13. Influence of azathioprine (imuran) on in vitro immune function in multiple sclerosis.
Oger JJ; Antel JP; Kuo HH; Arnason BG
Ann Neurol; 1982 Feb; 11(2):177-81. PubMed ID: 6462102
[TBL] [Abstract][Full Text] [Related]
14. Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling.
Sacca R; Cuff CA; Lesslauer W; Ruddle NH
J Immunol; 1998 Jan; 160(1):485-91. PubMed ID: 9552007
[TBL] [Abstract][Full Text] [Related]
15. A novel lymphokine derived from human IgG Fc receptor-bearing B cells: its suppressive effect on activated T and B lymphocytes including tumour cells in vitro.
Suzuki T; Park YH; Miyama-Inaba M; Masuda T; Saji H; Nagata I; Uchino H
Immunology; 1985 Jul; 55(3):427-36. PubMed ID: 3160654
[TBL] [Abstract][Full Text] [Related]
16. T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis.
Maimone D; Reder AT; Gregory S
Cell Immunol; 1993 Jan; 146(1):96-106. PubMed ID: 8425234
[TBL] [Abstract][Full Text] [Related]
17. Influx of nonactivated T lymphocytes into the cerebrospinal fluid during relapse of multiple sclerosis.
Oksaranta O; Tarvonen S; Ilonen J; Poikonen K; Reunanen M; Panelius M; Salonen R
Ann Neurol; 1995 Sep; 38(3):465-8. PubMed ID: 7668836
[TBL] [Abstract][Full Text] [Related]
18. The effect of a factor from multiple sclerosis serum on isolated T and B lymphocytes.
Armentrout SA; Sweet PM; Galant SP
J Clin Lab Immunol; 1981 May; 5(3):133-6. PubMed ID: 6972451
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10-modulated immature dendritic cells control the proinflammatory environment in multiple sclerosis.
Adikari SB; Pettersson A; Soderstrom M; Huang YM; Link H
Scand J Immunol; 2004 Jun; 59(6):600-6. PubMed ID: 15182256
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
Raine CS; Bonetti B; Cannella B
Rev Neurol (Paris); 1998 Sep; 154(8-9):577-85. PubMed ID: 9809372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
